Comparative Assessment of the Anticoagulant Activity of Rivaroxaban and Dabigatran in Patients With Nonvalvular Atrial Fibrillation: A Noninterventional Study

There is a shortage of data in everyday clinical practice about the anticoagulant effects caused by the new oral anticoagulants (NOAs). Our aim was to estimate the intensity of anticoagulant activity induced by rivaroxaban 20 mg qd and dabigatran 110 mg bid among patients with nonvalvular atrial fib...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsantes, Argirios E., Kyriakou, Elias, Ikonomidis, Ignatios, Katogiannis, Konstantinos, Papadakis, Ioannis, Douramani, Panagiota, Kopterides, Petros, Kapsimali, Violetta, Lekakis, John, Tsangaris, Iraklis, Bonovas, Stefanos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998746/
https://www.ncbi.nlm.nih.gov/pubmed/27057830
http://dx.doi.org/10.1097/MD.0000000000003037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998746/
https://www.ncbi.nlm.nih.gov/pubmed/27057830
http://dx.doi.org/10.1097/MD.0000000000003037

Ejemplares similares